Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 1
1993 1
1994 1
1996 1
1997 1
1998 1
1999 1
2000 2
2001 2
2004 1
2005 1
2006 1
2007 1
2008 1
2009 1
2010 1
2012 3
2013 2
2014 3
2015 2
2016 3
2017 2
2018 6
2019 3
2020 2
2021 7
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations.
Pekarek L, De la Torre-Escuredo B, Fraile-Martinez O, García-Montero C, Saez MA, Cobo-Prieto D, Guijarro LG, Saz JV, De Castro-Martinez P, Torres-Carranza D, Pekarek T, Carrera AC, Alvarez-Mon M, Ortega MA. Pekarek L, et al. Int J Mol Sci. 2022 Nov 29;23(23):14939. doi: 10.3390/ijms232314939. Int J Mol Sci. 2022. PMID: 36499267 Free PMC article. Review.
Diagnosis requires numerous imaging tests that make it possible to stratify both the local involvement of the disease and its distant spread, which ominously determines the prognosis. Thanks to various clinical trials, the usefulness of different chemotherapy regimens, rad …
Diagnosis requires numerous imaging tests that make it possible to stratify both the local involvement of the disease and its distant spread …
Skeletal Survey in Multiple Myeloma: Role of Imaging.
Spinnato P, Filonzi G, Conficoni A, Facchini G, Ponti F, Sambri A, De Paolis M, Cavo M, Salizzoni E, Nanni C. Spinnato P, et al. Curr Med Imaging. 2021;17(8):956-965. doi: 10.2174/1573405617666210126155129. Curr Med Imaging. 2021. PMID: 33573573 Review.
MRI is the gold-standard for the detection of bone marrow involvement, while PET/CT is the preferred technique in the assessment of response to therapy. Both MRI and PET/CT are able to provide prognostic information....
MRI is the gold-standard for the detection of bone marrow involvement, while PET/CT is the preferred technique in the assessment of response …
Clinical differences between central and peripheral chondrosarcomas.
Laitinen MK, Evans S, Stevenson J, Sumathi V, Kask G, Jeys LM, Parry MC. Laitinen MK, et al. Bone Joint J. 2021 May;103-B(5):984-990. doi: 10.1302/0301-620X.103B5.BJJ-2020-1082.R2. Bone Joint J. 2021. PMID: 33934657
Most studies group central and peripheral chondrosarcomas together, although there is growing evidence that their clinical behaviour and prognosis differ. The aims of this study were to analyze any differences in characteristics between central and peripheral chondrosarcom …
Most studies group central and peripheral chondrosarcomas together, although there is growing evidence that their clinical behaviour and …
Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous Differentiation.
Dhinsa BS, DeLisa M, Pollock R, Flanagan AM, Whelan J, Gregory J. Dhinsa BS, et al. Oncol Res Treat. 2018;41(7-8):456-460. doi: 10.1159/000487803. Epub 2018 Jun 15. Oncol Res Treat. 2018. PMID: 29902785
Due to its relatively low incidence, previous studies have grouped different histiotypes together to achieve adequate study numbers for analysis. METHODS: This retrospective study examines the clinical course and the role of chemotherapy in the subgroup of patients with DD …
Due to its relatively low incidence, previous studies have grouped different histiotypes together to achieve adequate study numbers for anal …
CDKL3 promotes osteosarcoma progression by activating Akt/PKB.
He A, Ma L, Huang Y, Zhang H, Duan W, Li Z, Fei T, Yuan J, Wu H, Liu L, Bai Y, Dai W, Wang Y, Li H, Sun Y, Wang Y, Wang C, Yuan T, Yang Q, Tian S, Dong M, Sheng R, Xiang D. He A, et al. Life Sci Alliance. 2020 Mar 31;3(5):e202000648. doi: 10.26508/lsa.202000648. Print 2020 May. Life Sci Alliance. 2020. PMID: 32234750 Free PMC article.
Our findings identify CDKL3 as a critical regulator that stimulates OS progression by enhancing Akt activation. CDKL3 represents both a biomarker for OS prognosis, and a potential therapeutic target in precision medicine by targeting CDKL3 to treat Akt hyper-activated OS.. …
Our findings identify CDKL3 as a critical regulator that stimulates OS progression by enhancing Akt activation. CDKL3 represents both a biom …
Vitamin D Represses the Aggressive Potential of Osteosarcoma.
Tahbazlahafi B, Paknejad M, Khaghani S, Sadegh-Nejadi S, Khalili E. Tahbazlahafi B, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(7):1312-1318. doi: 10.2174/1871530320666200821155756. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32955002
BACKGROUND: Osteosarcoma (OS) is the basic bone neoplasm with lower survival and poor prognosis. It is distinguished by its offensive nature and metastatic potential. ...OBJECTIVE: The present study aimed to analyze the effect of different concentrations of 1,25(OH)2D on t …
BACKGROUND: Osteosarcoma (OS) is the basic bone neoplasm with lower survival and poor prognosis. It is distinguished by its offensive …
Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment.
Shanmugavadivu A, Lekhavadhani S, Miranda PJ, Selvamurugan N. Shanmugavadivu A, et al. Biomed Mater. 2024 Feb 26;19(2). doi: 10.1088/1748-605X/ad270b. Biomed Mater. 2024. PMID: 38324905 Review.
Osteosarcoma (OS) is a malignant bone neoplasm plagued by poor prognosis. Major treatment strategies include chemotherapy, radiotherapy, and surgery. ...
Osteosarcoma (OS) is a malignant bone neoplasm plagued by poor prognosis. Major treatment strategies include chemotherapy, radiothera …
Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms.
Zhang T, Wan CY, Mei XL, Jia P, Wang MJ. Zhang T, et al. Med Sci Monit. 2018 Aug 18;24:5754-5760. doi: 10.12659/MSM.910220. Med Sci Monit. 2018. PMID: 30120220 Free PMC article.
We then observed that the expression level of lncRNA HULC was negatively correlated with overall survival rate of bone neoplasm patients, which means that lncRNA HULC has prognostic value in patients with bone neoplasms. Thus, we assessed the influence of lncRNA HULC down- …
We then observed that the expression level of lncRNA HULC was negatively correlated with overall survival rate of bone neoplasm patients, wh …
Osteosarcoma of the jaw bones.
Chindia ML. Chindia ML. Oral Oncol. 2001 Oct;37(7):545-7. doi: 10.1016/s1368-8375(00)00129-9. Oral Oncol. 2001. PMID: 11564573 Review.
Notably, the advent of adjuvant and neoadjuvant cytotoxic chemotherapy as an adjunct to radical surgery has greatly improved the prognosis of many cases of OS of the jaw bones....
Notably, the advent of adjuvant and neoadjuvant cytotoxic chemotherapy as an adjunct to radical surgery has greatly improved the prognosi …
55 results